Sartorius Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Joachim Kreuzburg

Chief executive officer

€1.8m

Total compensation

CEO salary percentage	59.5%
CEO tenure	22yrs
CEO ownership	0.04%
Management average tenure	4.3yrs
Board average tenure	7.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Joachim Kreuzburg's remuneration changed compared to Sartorius's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	€77m
Jun 30 2024	n/a	n/a	€78m
Mar 31 2024	n/a	n/a	€149m
Dec 31 2023	€2m	€1m	€205m
Sep 30 2023	n/a	n/a	€358m
Jun 30 2023	n/a	n/a	€495m
Mar 31 2023	n/a	n/a	€566m
Dec 31 2022	€2m	€1m	€678m
Sep 30 2022	n/a	n/a	€534m
Jun 30 2022	n/a	n/a	€489m
Mar 31 2022	n/a	n/a	€434m
Dec 31 2021	€3m	€1m	€319m
Sep 30 2021	n/a	n/a	€372m
Jun 30 2021	n/a	n/a	€332m
Mar 31 2021	n/a	n/a	€254m
Dec 31 2020	€2m	€903k	€210m
Sep 30 2020	n/a	n/a	€181m
Jun 30 2020	n/a	n/a	€154m
Mar 31 2020	n/a	n/a	€165m
Dec 31 2019	€2m	€888k	€157m
Sep 30 2019	n/a	n/a	€171m
Jun 30 2019	n/a	n/a	€166m
Mar 31 2019	n/a	n/a	€153m
Dec 31 2018	€2m	€863k	€141m
Sep 30 2018	n/a	n/a	€138m
Jun 30 2018	n/a	n/a	€126m
Mar 31 2018	n/a	n/a	€115m
Dec 31 2017	€2m	€832k	€115m

Compensation vs Market: Joachim's total compensation ($USD1.88M) is below average for companies of similar size in the UK market ($USD5.74M).

Compensation vs Earnings: Joachim's compensation has been consistent with company performance over the past year.

CEO

Joachim Kreuzburg (59 yo)

22yrs

Tenure

€1,783,000

Compensation

Dr. rer. pol. Joachim Kreuzburg serves as the Chairman and Chief Executive Officer at Sartorius Stedim Biotech GmbH.Dr. rer. pol. Kreuzburg has been the Chairman of Executive Board at Sartorius Aktiengese...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Joachim Kreuzburg	Chairman of Executive Board & CEO	22yrs	€1.78m	0.040% € 5.2m
Rene Faber	Head of Bioprocess Solutions Division & Member of Executive Board	5.8yrs	€906.00k	no data
Alexandra Gatzemeyer	Head of the Lab Products & Services Division and Member of Executive Board	1.5yrs	€537.00k	no data
Petra Kirchhoff	Head of Corporate Communications & Investor Relations and Member of Supervisory Board	7.9yrs	€82.00k	no data
Florian Funck	CFO & Member of Executive Board	less than a year	no data	no data
Patricia Spannagel	Head of Quality Assurance - Mechatronics Division Goettingen	no data	no data	no data
Ralf Mohrschladt	Physicist & Head of Supply Chain Management - Germany	no data	no data	no data
Petra Muller	Head of Investor Relations	2.8yrs	no data	no data
Maurice Phelan	President of Sartorius North America	1.8yrs	no data	no data
Theo Thijssen	President of Environmental Technology Division	23.1yrs	no data	no data

4.3yrs

Average Tenure

53yo

Average Age

Experienced Management: SRT3D's management team is considered experienced (4.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Petra Kirchhoff	Head of Corporate Communications & Investor Relations and Member of Supervisory Board	14.1yrs	€82.00k	no data
Klaus Trutzschler	Independent Member of Supervisory Board	13yrs	€186.00k	no data
Annette Becker	Employee Representative Member of Supervisory Board	22.2yrs	€120.00k	no data
Frank Riemensperger	Member of Supervisory Board	2.7yrs	€81.00k	no data
Lothar Kappich	Chairman of Supervisory Board	17.6yrs	€365.00k	no data
Daniela Favoccia	Independent Member of Supervisory Board	7.6yrs	€82.00k	no data
Manfred Zaffke	Employee Representative Vice Chairman of Supervisory Board	10.7yrs	€201.00k	no data
Ilke Panzer	Independent Member of Supervisory Board	7.6yrs	€82.00k	no data
David Ebsworth	Independent Member of Supervisory Board	4.8yrs	€82.00k	no data
Dietmar Muller	Employee Representative Member of Supervisory Board	4.5yrs	€118.00k	no data
Hermann Ritzau	Member of Supervisory Board	3.7yrs	€82.00k	no data
Sabrina Wirth	Member of the Supervisory Board	2.7yrs	€81.00k	no data

7.6yrs

Average Tenure

60yo

Average Age

Experienced Board: SRT3D's board of directors are considered experienced (7.6 years average tenure).

Sartorius Management

Management criteria checks 4/4

Key information

Recent management updates

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 28, 2024

Sartorius Announces Executive Board Changes

Sartorius Announces Management Changes for Sartorius North America

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 29, 2023

Recent updates

Sartorius Aktiengesellschaft to Report Fiscal Year 2024 Results on Jan 28, 2025

Labforward GmbH acquired LabTwin GmbH from Sartorius Aktiengesellschaft (XTRA:SRT3).

First quarter 2024 earnings released

Dividend of €0.74 announced

Sartorius Aktiengesellschaft to Report Fiscal Year 2023 Final Results on Feb 16, 2024

Sartorius Aktiengesellschaft to Report Q3, 2024 Results on Oct 17, 2024

Sartorius Aktiengesellschaft to Report Fiscal Year 2023 Results on Jan 26, 2024

Third quarter 2023 earnings released

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 28, 2024

Investor sentiment deteriorates as stock falls 17%

Sartorius Ag Lowers Earnings Forecast for the Fiscal Year 2023

Sartorius Announces Executive Board Changes

Second quarter 2023 earnings released

New minor risk - Share price stability

First quarter 2023 earnings released

Upcoming dividend of €1.44 per share at 0.4% yield

Sartorius Aktiengesellschaft Provides Revenue Guidance for the Full Year 2023

Investor sentiment improved over the past week

Sartorius Announces Management Changes for Sartorius North America

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 29, 2023

Sartorius Aktiengesellschaft to Report Nine Months, 2023 Results on Oct 19, 2023

Investor sentiment improved over the past week

Sartorius Aktiengesellschaft Confirms Consolidated Financial Guidance for the Year 2022

Sartorius AG Proposes Ordinary Dividend for the Year 2021

Sartorius Aktiengesellschaft Provides Consolidated Sales Revenue Guidance for the Fiscal Year 2022 and Reaffirms Consolidated Sales Revenue for the Year 2025

Sartorius Aktiengesellschaft (XTRA:SRT) entered into an agreement to acquire a 62.5% stake in ALS Automated Lab Solutions GmbH.

Sartorius Provides Earnings Guidance for the First Half Ended June 30, 2021

Sartorius Raises Group Earnings Guidance for the Full Year 2021

Sartorius Plans to Acquire Remaining Shares of Cellgenix

Sartorius AG Raises Revenue Guidance for the Year 2021

Sartorius Revises Earnings Guidance for the Year 2021

Sartorius Aktiengesellschaft to Report Fiscal Year 2020 Final Results on Feb 18, 2021

Sartorius Aktiengesellschaft to Report Q1, 2021 Results on Apr 21, 2021

Sartorius Aktiengesellschaft (XTRA:SRT) agreed to acquire just over 50% stake in Biological Industries Israel Beit Haemek Ltd. from Kibbutz Beit Haemek and Fortissimo Capital, L.P. managed by Fortissimo Capital for approximately €45 million.

Sartorius Aktiengesellschaft to Report Q3, 2020 Results on Oct 20, 2020

Sartorius Aktiengesellschaft (XTRA:SRT) and Sartorius Stedim Biotech S.A. (ENXTPA:DIM) completed the acquisition of certain businesses from Danaher Corporation (NYSE:DHR).

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age